RMSF is the most deadly tick-borne disease in the United States.
Annually 3,000-5,000 cases of RMSF and other spotted fever rickettsioses
are reported in the United States, including 5-10 deaths and
substantially more severe cases. However, effective treatment is
available, and severe and fatal cases of RMSF can be prevented though
early recognition and treatment. The Centers for Disease Control and
Prevention has developed a clinical toolkit for healthcare providers,
epidemiologists, and public health practitioners on the diagnosis and
treatment of RMSF and other tick-borne diseases. Key learning
objectives of the toolkit include:
RMSF is a rapidly progressing tick-borne disease with early stage
Doxycycline is the drug of choice for treating people of all ages.
Treatment is most effective when started within the first 5 days